Aspira Pathlab & Diagnostics

Sector: Healthcare

Followers

5
5
9
9
.
9
9
5
5
0.71 (1.20%)

As on 16 Apr, 2026 | 16:01

Open Trading A/c
Day Range
55.10
60.50
LH
52 Week Range
49.00
81.00
LH
Volume
* i
Bid / Ask
1,194.00
0.00 / 0.00

Aspira Pathlab & Diagnostics Announcements

Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement and Corrignendum to the Detailed Public Statement under...

13 Apr, 2026 | 04:51pm • Source: BSE

Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendation of the Independent Director Committee ('IDC') in relation to...

10 Apr, 2026 | 07:39pm • Source: BSE

Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer to the Public Shareholders of Aspira Pathlab...

07 Apr, 2026 | 03:43pm • Source: BSE

Intimation of Closure of Trading Window

26 Mar, 2026 | 05:12pm • Source: BSE

Aftertrade Broking Pvt Ltd ("Manager to the Offer") has informed BSE regarding Intimation of Identified Date for the Proposed Open Offer of Aspira Pathlab &...

25 Mar, 2026 | 12:01pm • Source: BSE

Newspaper Advertisement regarding Special Window Re-Lodgement for Transfer & Dematerialisation of Physical Securities.

26 Feb, 2026 | 06:16pm • Source: BSE

Newspaper Publication for Unaudited Standalone Financial Results for the third quarter & nine months ended on 31.12.2025

12 Feb, 2026 | 02:50pm • Source: BSE

Q3/2025-26 Financial Results

10 Feb, 2026 | 07:26pm • Source: BSE

Approval of the Unaudited Standalone Financial Results for third quarter and nine months ended on December 31, 2025

10 Feb, 2026 | 07:05pm • Source: BSE

Outcome of Postal Ballot

06 Feb, 2026 | 08:41pm • Source: BSE

Voting Results & Scrutinizer Report of Postal Ballot conducted by remote e-voting process.

06 Feb, 2026 | 07:18pm • Source: BSE

Compliance Certificate under reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2025

07 Jan, 2026 | 05:04pm • Source: BSE

Newspaper Publication-Postal Ballot

07 Jan, 2026 | 04:54pm • Source: BSE

Intimation of Postal Ballot Notice for appointment of Mrs. Kiran Awasthi (DIN:09066721) as an Independent Director for the first term of 5 consecutive years

06 Jan, 2026 | 05:09pm • Source: BSE

Revised disclosure pertaining to the demise of Dr. Alaka Keshav Deshapande ,pursuant to the observation email received from BSE

05 Jan, 2026 | 07:02pm • Source: BSE

Demise of Independent Director - Dr. Alaka Keshav Deshpande (DIN:11238406)

02 Jan, 2026 | 08:57pm • Source: BSE

Intimation of Closure of Trading Window for the quarter ended December 31, 2025.

29 Dec, 2025 | 06:15pm • Source: BSE

Appointment of Mrs. Kiran Raghavendra Awsathi (DIN:09066721) as Additional Independent Director subject to the members approval.

12 Nov, 2025 | 09:35pm • Source: BSE

The Company has acquired the business undertaking of Aspira DNA Diagnostics Gujarat LLP on a slump sale basis pursuant to the BTA Agreement as on...

12 Nov, 2025 | 09:19pm • Source: BSE

Outcome of Board Meeting held on November 12, 2025

12 Nov, 2025 | 08:23pm • Source: BSE